A serial entrepreneur since 1979, Nina Vikhrieva is the CEO and co-owner of two companies: premium aesthetics device designer Premium Aesthetics Ltd. She champions innovation in the pharmaceutical, medical and biotechnology sectors, favoring offerings that have high commercial potential and social impact. Currently, she is participating in several biotechnological projects, including the creation and launch of original drugs for the treatment of type 2 diabetes, breast cancer, proliferative diseases of the endometrium, as well as clinical research in various fields of medicine including stem cell technology.
Vikhrieva concurrently served as CEO and co-owner of both Premium Aesthetics Ltd. and Ekomir Group, one of Russia’s Top 10 nutraceutical manufacturers between 2005 and 2013. Before that, she was the commercial director of textile holding GUTA Group, representing a career shift from her three years at Eli Lilly, where she climbed the ranks from medical representative to special projects manager in Moscow. She began her career as an anesthesiologist and—over the course of 14 years at the Regional Burn Center of Yekaterinburg—became the head of the resuscitation and intensive therapy division. She is a graduate of the Yekaterinburg State Medical Academy in Russia.